LENALIDOMIDE
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment in combination with dexamethasone, of newly diagnosed disease in
a patient ineligible for stem cell transplantation
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment until progression in patients initiated on dual combination therapy
(this drug and dexamethasone), or, in patients initiated on triple therapy (this drug,
bortezomib and dexamethasone during treatment cycles 1 up to 8) and are now being
treated with treatment cycle 9 or beyond
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 0 | DPMQ: $372.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment in combination with dexamethasone, of newly diagnosed disease in
a patient ineligible for stem cell transplantation
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment until progression in patients initiated on dual combination therapy
(this drug and dexamethasone), or, in patients initiated on triple therapy (this drug,
bortezomib and dexamethasone during treatment cycles 1 up to 8) and are now being
treated with treatment cycle 9 or beyond
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 0 | DPMQ: $396.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment with triple therapy (this drug, bortezomib and dexamethasone) for
the first 4 treatment cycles (cycles 1 to 4) administered in a 21-day treatment cycle
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment of triple therapy (this drug, bortezomib and dexamethasone) for
treatment cycles 5 to 8 inclusive (administered using 21-day treatment cycles)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 14 | # of repeats: 3 | DPMQ: $248.50 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment of triple therapy (this drug, bortezomib and dexamethasone) for
treatment cycles 5 and 6 (administered using 28-day treatment cycles)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 1 | DPMQ: $396.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment of triple therapy (this drug, bortezomib and dexamethasone) for
treatment cycles 5 and 6 (administered using 28-day treatment cycles)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 1 | DPMQ: $372.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment with triple therapy (this drug, bortezomib and dexamethasone) for
the first 4 treatment cycles (cycles 1 to 4) administered in a 21-day treatment cycle
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment of triple therapy (this drug, bortezomib and dexamethasone) for
treatment cycles 5 to 8 inclusive (administered using 21-day treatment cycles)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 14 | # of repeats: 3 | DPMQ: $267.32 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Triple combination therapy consisting of elotuzumab, lenalidomide and dexamethasone
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 2 | DPMQ: $396.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Triple combination therapy consisting of elotuzumab, lenalidomide and dexamethasone
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 2 | DPMQ: $372.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment as monotherapy or dual combination therapy with dexamethasone for
progressive disease
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment as monotherapy or dual combination therapy with dexamethasone
following initial treatment for progressive disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 0 | DPMQ: $372.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment as monotherapy or dual combination therapy with dexamethasone for
progressive disease
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment as monotherapy or dual combination therapy with dexamethasone
following initial treatment for progressive disease
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 0 | DPMQ: $396.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lenalide | |||||
| Lenalidomide Dr.Reddy's | |||||
| Lenalidomide Sandoz | |||||
| Revlimid | |||||